Jamaica is an important market for U.S. bulk agricultural products, intermediate products and high value products, with a total value of approximately USD 378 million in 2017. In Jamaica, there is currently no commercial production of genetically engineered (GE) crops. In addition, Jamaica does not have a biotechnology or biosafety legal framework for the deregulation or commercialization of biotechnology crops and does not have specific requirements for GE imports. There are current regulations that governs the importation of GE products for experimental purposes. In addition, Jamaica’s draft biotechnology policy, which has been in draft form for several years, explicitly states the need for mandatory labeling of GE products.